Sheba Medical Center ( Site 1602)

Ramat Gan 5265601

1 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Triple Negative Breast Neoplasms

Studies at this site

• A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009) — Recruiting now
• Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522) — Completed